These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9512112)

  • 1. Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.
    Hahm KB; Lee KJ; Kim YS; Kim JH; Cho SW; Yim H; Joo HJ
    Dig Dis Sci; 1998 Feb; 43(2):235-40. PubMed ID: 9512112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative and qualitative usefulness of rebamipide in eradication regimen of Helicobacter pylori.
    Hahm KB; Lee KJ; Kim YS; Kim JH; Cho SW; Yim H; Joo HJ
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):192S-197S. PubMed ID: 9753249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
    Louw JA; Van Rensburg CJ; Moola S; Kotze D; Marks IN
    Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
    Kato M; Asaka M; Sugiyama T; Kudo M; Nishikawa K; Sukegawa M; Hokari K; Katagiri M; Sato F; Kagaya H; Takeda H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):198S-202S. PubMed ID: 9753250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
    Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
    Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
    Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H
    J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
    Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
    Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short-term eradication therapy for Helicobacter pylori acute gastritis.
    Nomura H; Miyake K; Kashiwagi S; Sugiyama T; Asaka M
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1377-81. PubMed ID: 11197046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent eradication of Helicobacter pylori with dual therapy.
    Treiber G; Ammon S; Klotz U
    Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
    Nebiki H; Higuchi K; Arakawa T; Ando K; Uchida T; Ito H; Harihara S; Kuroki T; Kobayashi K
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):203S-206S. PubMed ID: 9753251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy.
    Saita H; Murakami M; Takahashi Y; Sou Y; Kaitani K; Nishio K; Kita T
    J Gastroenterol Hepatol; 1998 Jul; 13(7):725-31. PubMed ID: 9715425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
    Terano A; Arakawa T; Sugiyama T; Yoshikawa T; Haruma K; Asaka M; Shimosegawa T; Sakaki N; Ishii H; Sakamoto C; Takahashi S; Kinoshita Y; Fujioka T; Kobayashi K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):103-9. PubMed ID: 16706820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication.
    Suzuki M; Mori M; Miyayama A; Iwai N; Tsunematsu N; Oonuki M; Suzuki H; Hibi T; Ishii H
    J Clin Gastroenterol; 1997; 25 Suppl 1():S222-8. PubMed ID: 9479652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
    Suzuki M; Kitahora T; Nagahashi S; Suzuki H; Mori M; Hibi T; Ishii H
    J Clin Gastroenterol; 1998; 27 Suppl 1():S183-6. PubMed ID: 9872519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of Helicobacter pylori in patients with end-stage renal disease under dialysis treatment.
    Tamura H; Tokushima H; Murakawa M; Matsumura O; Itoyama S; Sekine S; Hirose H; Mitarai T; Isoda K
    Am J Kidney Dis; 1997 Jan; 29(1):86-90. PubMed ID: 9002534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.
    Furuta T; Shirai N; Xiao F; El-Omar EM; Rabkin CS; Sugimura H; Ishizaki T; Ohashi K
    Clin Gastroenterol Hepatol; 2004 Jan; 2(1):22-30. PubMed ID: 15017629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.